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Smooth musclef the upper airways, caused by many different genetic and environmental insults,
is known as tracheomalacia in humans. We determined that Tmem16a, a member of an evolutionarily
conserved family of predicted transmembrane proteins, is expressed in the developing trachea. We report
that all mice homozygous for a null allele of Tmem16a died within one month of birth and exhibited severe
tracheomalacia with gaps in the tracheal cartilage rings along the entire length of the trachea. In addition, the
development of the trachealis muscle that spans the dorsal aspect of the trachea was abnormal in Tmem16a
mutants. Since the chondrogenic mesenchyme does not express Tmem16a at any time, we propose that the
cartilage ring defect observed in Tmem16a mutants is secondary to an expansion of the embryonic trachea
that might result from improper stratiﬁcation of the embryonic tracheal epithelium or the abnormal
trachealis muscle. Our data identify Tmem16a as a novel regulator of epithelial and smooth muscle cell
organization in murine development. This mutant, the ﬁrst knockout of a vertebrate TMEM16 family
member, provides a mouse model of tracheomalacia.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe murine respiratory system is ﬁrst recognizable as two primary
lung buds emerge from the ventral foregut endoderm on embryonic
day (E) 9.5 (reviewed in Cardoso and Lu (2006)). These buds elongate
and branch in an iterative process, known as branching morphogen-
esis, to generate the distal respiratory tree. The foregut endoderm
rostral to the site of the primary lung buds gives rise to two epithelial
tubes: the esophagus and trachea. The mechanisms governing the
separation of these two tubes are not entirely clear, but errors in this
process carry signiﬁcant clinical implications in the forms of
tracheoesophageal ﬁstula and esophageal atresia (Que et al., 2006).
C-shaped rings of hyaline cartilage encircle the ventrolateral
surfaces of the mature trachea and prevent its collapse during
respiration. In humans, structural weakness of the trachea, known
as tracheomalacia, results in collapse of the airway during respiration
(for reviews see Carden et al. (2005), McNamara and Crabbe (2004)).
Depending on the degree of tracheal collapse, symptoms range from
respiratory stridor to fatal airway obstruction. The true incidence ofh Complex, 1376 Mowry Road,
of North Carolina, Chapel Hill,
l rights reserved.tracheomalacia is not known because many of its symptoms overlap
with those of other pulmonary disorders and it is often misdiagnosed;
however, estimates range from 1 in 2600 to 1 in 1445 births (Boogaard
et al., 2005; Carden et al., 2005). In some instances, tracheomalacia
arises through developmental malformation of the trachea itself; this
congenital form is known as primary tracheomalacia (reviewed in
Carden et al. (2005)). Examples of primary tracheomalacia include
defects in cartilage matrix production or the shortened cartilage
elements observed in patients with tracheoesophageal ﬁstula. In other
cases, classiﬁed as secondary tracheomalacia, the cause of tracheal
collapse is extrinsic to the trachea. Examples of secondary tracheo-
malacia include trauma and external pressure on the trachea from
adjacent organs.
In mice, the tracheal cartilage rings develop in the splanchnic
mesenchyme surrounding the trachea between embryonic day (E)
13.5 and E15.5 (Miller et al., 2004). Sox9, a gene necessary for
chondrogenesis, is expressed in bilateral longitudinal stripes along the
length of the trachea at E9.0 (Elluru and Whitsett, 2004). The
expression of Col2a1, a major component of the extracellular matrix
of cartilage, has been reported in similar domains beginning a day
later at E10.0 (Elluru and Whitsett, 2004). The mechanisms directing
the development of tracheal cartilage rings in distinct bands along the
rostrocaudal axis in the ventrolateral mesenchyme are not currently
known; however, reverse genetic experiments in mice have identiﬁed
several genes that affect their development. These include Shh (Miller
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FoxF1 (Mahlapuu et al., 2001), Raldh2 (Vermot et al., 2003), Wnt7b
(Rajagopal et al., 2008), Fgfr2c (Eswarakumar et al., 2004), and various
retinoic acid receptors (Mendelsohn et al., 1994). Unfortunately, the
characterizations of these mutants have focused on other defects and
the molecular events underlying their tracheal cartilage malforma-
tions have not been investigated.
The dorsal aspect of the trachea is not cartilaginous; instead, the
trachealis muscle spans a gap in each cartilage ring. This smooth
muscle regulates the lumen size of the trachea and, along with the
cartilage rings, keeps the airway open during respiration (Hakansson
et al., 1976). Surprisingly little is known about the embryology of the
trachealis muscle and the genes affecting its development.
Tmem16a is a member of the TMEM16 family of proteins with
orthologs in organisms ranging from Saccharomyces cerevisiae to
humans (Entian et al., 1999; Katoh and Katoh, 2003). These proteins
contain eight predicted transmembrane domains and a C-terminal
domain of unknown function (DUF590; Interpro IPR007632). Human
TMEM16A (other published names for this protein include DOG1,
TAOS2 and FLJ10621) is ampliﬁed in a number of cancers including oral
squamous cell carcinoma and gastrointestinal stromal tumors (Huang
et al., 2006; West et al., 2004). Despite this evolutionary conservation
and potential clinical signiﬁcance, the functions of the vertebrate
TMEM16 proteins are unknown.
We report that murine Tmem16a is expressed in the epithelium
of the developing trachea and in the embryonic trachealis muscle.
Mice homozygous for a null allele of Tmem16a failed to thrive
during postnatal life. These mice developed ventral gaps in the
tracheal rings along the entire rostrocaudal axis of the trachea and
abnormal trachealis muscles. Since Tmem16a is not expressed at any
stage in the chondrogenic ventrolateral mesenchyme, we propose
that the cartilage defect is secondary to defects in the epithelium or
trachealis where Tmem16a is expressed. We provide evidence that
the defective trachealis muscles and abnormally organized tracheal
epithelium in Tmem16a mutant embryos resulted in an abnormal
expansion of the trachea that displaced the ventral chondrocytes
or changed their identity to a non-chondrogenic lineage. This
phenotype caused symptoms that mimic those in humans with
tracheomalacia.
Materials and methods
Generation of a null allele of Tmem16a
Arms of homology ﬂanking exon 12 of Tmem16a were PCR
ampliﬁed from CJ.7 ES cell genomic DNA and cloned into an ES cell
targeting vector containing a ﬂoxed PGK-neo cassette. The linearized
targeting construct was electroporated into 129S1/SvImj derived CJ.7
ES cells (Swiatek and Gridley,1993) and targeted clones were enriched
for by selection with Geneticin (Invitrogen, Carlsbad, CA) and FIAU
(Moravek Biochemicals, Brea, CA). Southern blotting conﬁrmed the
correct targeting of one ES cell line that was used to generate chimeras
by blastocyst injections. Germline transmission of the correctly
targeted allele was conﬁrmed by PCR. All experiments were approved
by and performed according to the regulations of the Institutional
Animal Care and Use Committee of the University of Florida.
mRNA was isolated from E11.0 mutant embryos using TRIzol
(Invitrogen, Carlsbad, CA) according to the manufacturer's manufac-
turer's protocol and used to generate cDNA using AMV reverse
transcriptase and oligo(dT) primers. Primers ﬂanking the deletion
were used to amplify the targeted Tmem16a transcript that was cloned
and sequenced to conﬁrm deletion of exon 12 and the downstream
frameshift mutation.
Dams or pupswere sacriﬁced by cervical location or carbon dioxide
asphyxiation and embryos or tracheae were isolated in PBS prior to
ﬁxation overnight at 4 °C in 4% paraformaldehyde. Samples weredehydrated, inﬁltrated with HistoWax (Leica Microsystems, Bannock-
burn, IL), and embedded in parafﬁn. Seven micrometer sections were
cut on a rotary microtome. For BrdU incorporation, dams were
injected with 10 μl/g body weight of 3 mg/ml BrdU in PBS 2 h prior to
sacriﬁce.
Alcian blue staining of cartilage
Whole tracheae or dewaxed and rehydrated 7 μm parafﬁn sections
were stained in 0.03% alcian blue (Fisher Scientiﬁc, Pittsburgh, PA) in
25% glacial acetic acid in ethanol. Whole mount samples were cleared
by immersion in KOH and glycerol. Sections were counterstained in
eosin, dehydrated, and mounted.
RNA in situ hybridization
RNA in situ hybridizations were performed on whole lungs or
14 μm cryosections according to a standard protocol (Nieto et al.,
1996). The plasmid used to generate antisense probe for Tmem16a has
been described previously (Rock et al., 2007).
Immunohistochemistry and immunoﬂuorescence
Sections were dewaxed and rehydrated. Antigen retrieval was
performed by microwaving slides for 20 min in 10 mM citric acid
(pH6.0) with 0.05% Tween-20 (Fisher Scientiﬁc, Pittsburgh, PA).
Primary antibodies were used at the following concentrations: rabbit
anti-Sox9 at 1:200 (sc-20095, Santa Cruz Biotechnologies, Santa Cruz,
CA), goat anti-CC10 at 1:100 (sc-9772, Santa Cruz Biotechnologies)
(CC10 is also known as Scgb1a1), mouse anti-p63 at 1:200 (sc-8431,
Santa Cruz Biotechnologies), rat anti-Cdh1 at 1:200 (U3254, Sigma, St.
Louis, MO), mouse anti-acetylated α-tubulin at 1:100 (Ab24610,
Abcam, Cambridge, MA), mouse anti-α smooth muscle actin at 1:100
(clone 1A4, DAKO, Carpinteria, CA), and rat anti-BrdU at 1:50
(OBT0030G, Accurate Chemical, Westbury, NY). p63 was visualized
using the MOM kit and Sox9, α-smooth muscle actin, and BrdU were
visualized using VectaStain ABC kits (Vector Laboratories, Burlingame,
CA) and metal-enhanced DAB (Pierce Biotechnology, Rockford, IL).
Sections were counterstained with Richardson's Azure II. Secondary
antibodies for immunoﬂuorescence were: Cy2-conjugated donkey
anti-goat, Cy3-conjugated donkey anti-rat, and Cy3-conjugated
donkey anti-mouse (Jackson ImmunoResearch, West Grove, PA).
4′,6-Diamidino-2′-phenylindole (DAPI, Pierce Biotechnology, Rock-
ford, IL) was used as counterstain.
Immunocytochemistry
The 3.3 kb RsrII-NdeI fragment of EST AK052589 encoding
Tmem16a was blunted and ligated into XhoI digested and blunted
pAcGFP1-C1 (Clontech, Mountain View, CA). Sequencing the resulting
plasmid (pGFP-Tmem16a) conﬁrmed that Tmem16awas in frame 3′ of
the GFP coding sequence. KLN 205 cells (American Type Culture
Collection, Manassas, VA) were seeded at 105 cells per well 24 h prior
to transfection with 2 μg of pAcGFP1-C1 or pGFP-Tmem16a using
FuGENE 6 (Roche, Basel, Switzerland) according to the manufacturer's
protocol. Twenty-four hours after transfection GFP was immunoloca-
lized using polyclonal goat anti-GFP (ab5450, Abcam, Cambridge, MA)
and Cy-2 conjugated donkey anti-goat (Jackson ImmunoResearch,
West Grove, PA).
Image acquisition, measurement of luminal circumference, and
quantiﬁcation of proliferation
Images were acquired using a Leica DFC300 FX camera or Leica TCS
SP2 confocal system (Leica Microsystems, Bannockburn, IL). For
luminal measurement, images of histological sections of wild type
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Institutes of Health).
The apical epithelial surface for each image was traced and
converted from pixels to μm by measuring a micrometer in an
identical manner. Single litters were analyzed to minimize variation
due to staging and processing. Data shown is average±SEM. An
unpaired Student's t-test was performed to conﬁrm signiﬁcance of the
differences in tracheal circumferences at E14.5.
To quantify proliferation, BrdU-positive cells were counted and
divided by the total number of cells counted in 1 wild type and 1
mutant at E13.5 for the ventral mesenchyme (200 cells total for each)
or 2 animals of each genotype for the epithelium at E14.5. Data shown
is average±SEM.
Results
Tmem16a is expressed in the embryonic tracheal epithelium and
trachealis muscle
We performedwholemount and section RNA in situ hybridizations
with an antisense riboprobe to detect Tmem16a transcripts during
murine tracheal development. At E10.5 we observed Tmem16a
expression throughout the epithelia of the foregut and primary lung
buds (Fig. 1A). Tmem16a expression continued in the proximal airway
epithelium (trachea and conducting airways of the lung) at E11.5 and
E12.5, but was absent from the distal tips of peripheral lung
epithelium at these stages (Figs. 1B–D). At E14.5 and E16.5 Tmem16a
expressionwas detected in cells of the tracheal epithelium (Figs.1E, F).
In addition to epithelial expression, intense signal was observed in the
mesenchyme dorsal to the trachea (Figs. 1D–F). This dorsal mesench-
yme does not form cartilage but instead forms the trachealis muscle
which bridges the gaps in the cartilage rings. Tmem16a expressionwas
not detected in the chondrogenic mesenchyme of the ventrolateral
trachea at any stage examined (E10.5–E18.5).
TMEM16A is localized to the plasma membrane
Previous reports of immunohistochemistry on gastrointestinal
stromal tumor samples showed that human TMEM16A was localized
to the plasma membrane, while other members of the TMEM16
family of proteins have been reported on intracellular membranes
(Bera et al., 2004; Mizuta et al., 2007; West et al., 2004). Since
Tmem16a is expressed in the distal epithelial cells of the murine lung
at E18.5 (Fig. 1G), we used the cell line KLN 205, which is of murine
lung carcinoma origin, to examine the localization of TMEM16A
(Kaneko and LePage, 1978). Overexpression of a vector encoding green
ﬂuorescent protein (GFP) in these cells resulted in cytoplasmic
localization of GFP (Fig. 1H). In contrast, a GFP-TMEM16A fusion
protein was detected by immunoﬂuorescence on the plasma mem-
brane in KLN 205 cells (Fig. 1I).
Tmem16a null mice fail to thrive during postnatal life
To investigate the functions of Tmem16a in vertebrate develop-
ment, we generated a null allele of this gene by homologous
recombination inmurine embryonic stem (ES) cells (Fig. 2A). Germline
transmission of this allele, Tmem16atm1Bdh, was conﬁrmed by poly-
merase chain reaction (PCR). Mice heterozygous for Tmem16atm1Bdh
had no apparent phenotype and were mated to generate
Tmem16atm1Bdh/tm1Bdh pups (hereafter referred to as Tmem16a
mutants). rtPCR on Tmem16a mutant embryonic tissue conﬁrmed
that, by deleting exon 12 of Tmem16a, we had removed 53 amino acids
of the second transmembrane domain and the extracellular loop
between the ﬁrst and second transmembrane domains. This strategy
induced a frameshift mutation 3′ of the deletion that placed 7 of 8
Tmem16a transmembrane domains out-of-frame and resulted in apremature termination codon 40 amino acids downstream of the
deletion. In addition, the deletionwas predicted to aberrantly place the
truncated C-terminus extracellularly and prevent translation of the
DUF590 domain that is conserved in all TMEM16 proteins. These data
indicate that Tmem16atm1Bdh is a null allele of Tmem16a. Since only a
small exon was deleted, it was possible that a truncated form of
TMEM16A was made from this allele. Tmem16a heterozygotes were
phenotypically wild type, suggesting that if a truncated protein was
made it did not function in a dominant negative manner.
Greater than 90% of Tmem16a nulls died within the ﬁrst nine days
of postnatal life and no Tmem16a mutants survived longer than
30 days postpartum (Fig. 2B and data not shown). Tmem16a mutants
were born with the expected Mendelian frequency (19/81 or 27%)
and newborn mutants had a body weight similar to that of wild type
and heterozygous littermates (Fig. 2C). However, Tmem16a null
animals did not gain weight at the same rate as their littermates
(Fig. 2C). Three days after parturition, Tmem16a mutants weighed
only ~65% as much as their littermates. Tmem16a nulls that survived
21 days postpartum weighed less than half as much as wild type
littermates. Milk was observed in the stomachs of Tmem16a null pups
suggesting that these pups were able to locate nipples and initiate
suckling behavior.
A portion of Tmem16a null pups developed grossly distended
bellies within the ﬁrst postnatal week. Varying amounts of air were
encountered in the esophagi, stomachs, and intestines of all Tmem16a
null pups upon sacriﬁce and subsequent dissection (data not shown).
This aerophagia was frequently associated with a cyanotic appearance
prior to sacriﬁce and suggested a defect in the development of the
upper respiratory and/or digestive tracts in Tmem16amutants. Neither
gross nor histological examination of craniofacial development
revealed any obvious patterning defects of the palate, tongue, larynx,
or crania of Tmem16a null pups (data not shown).
Tmem16a mutants exhibit defects in tracheal cartilage ring formation
Because Tmem16a was expressed in the developing trachea and
the mutant phenotype was consistent with an upper airway anomaly,
tracheae were dissected from Tmem16a mutants and littermates and
stained with alcian blue to examine cartilage elements. Ventral gaps
were observed along the entire rostrocaudal axis of mutant tracheae
and the cartilage plates on the bronchi were also abnormally pa-
tterned (Fig. 2D and data not shown). Transverse sections of Tmem16a
mutant tracheae stained with alcian blue and eosin clearly demon-
strated multiple disconnected cartilage condensations with interven-
ing epithelial evaginations (compare Figs. 2E and F). This phenotype
was 100% penetrant in Tmem16amutants; all mutants examined on or
after E15.5 exhibited gaps in their cartilage rings (n= 16). In contrast,
wild type and heterozygous littermates never exhibited a disruption
in the normal cartilage ring pattern (n= 13). Development of the
thyroid and cricoid cartilages was not disrupted in Tmem16a mutants
(Fig. 2D and data not shown).
Chondrogenic cells are present in the ventral mesenchyme of Tmem16a
mutants
Tracheal cartilage rings develop in the splanchnic mesenchyme
surrounding the trachea between E13.5 and E15.5 (Miller et al., 2004).
Expression of Sox9, a high mobility group transcription factor, has
been reported in cells fated to form cartilage in the peritracheal
mesenchyme beginning at E9.0 (Elluru and Whitsett, 2004). Since
SOX9 is capable of activating the transcription of genes encoding
cartilage components including Col2a1 (Lefebvre et al., 1997) and
aggrecan (Sekiya et al., 2000), we utilized SOX9 as an early marker of
chondrogenesis. Immunohistochemistry and RNA in situ hybridization
revealed that SOX9-positive cells were present in the ventrolateral
tracheal mesenchyme of both wild type and Tmem16a mutant
Fig. 1. Tmem16a is expressed in the developing tracheal epithelium. (A) RNA in situ hybridization on a wild type E10.5 cryosection demonstrated Tmem16a expression throughout the
foregut endoderm and primary lung buds. (B, C) Whole mount RNA in situ hybridization showed Tmem16a expression persisted in the epithelium of the trachea and conducting
airways of the lung at E11.5 (B) and E12.5 (C). (D) Section RNA in situ hybridization showed Tmem16a expression in the tracheal epithelium and the mesenchyme dorsal to the trachea
(asterisk in panel D) at E12.5. (E, F) Expression of Tmem16a in the tracheal epithelium continued at E14.5 (E) and E16.5 (F). Robust Tmem16a expression was also observed in the
developing trachealis muscle at these stages. Tmem16a expression was also observed in the esophagus, aorta and thymus (D, E and data not shown). (G) RNA in situ hybridization
demonstrated expression of Tmem16a in distal epithelial cells of the lung at E18.5. (H) Overexpression of GFP in KLN 205 murine lung carcinoma cells resulted in cytoplasmic
distribution of the protein. (I) Overexpressed GFP-TMEM16A fusion proteinwas detected on the plasmamembrane. Abbreviations: Ao, aorta; Es, esophagus; Lb, lung bud; Te, tracheal
epithelium; Th, thymus; Tm, trachealis muscle; Tr, trachea. Scale bars (A, D–F)=100 μm; G=50 μm; (H, I)=10 μm.
144 J.R. Rock et al. / Developmental Biology 321 (2008) 141–149
Fig. 2. Tmem16a null mice die within the ﬁrst month of life and do not complete normal tracheal development. (A) Exon 12 of Tmem16a was replaced with a PGK-neo cassette by
homologous recombination in embryonic stem cells. XbaI cleavage sites are marked by an “X”. Red line indicates probe used for Southern blotting to assess targeting of ES cell
colonies. Properly targeted ES cells generated a 9.5 kb XbaI fragment; the wild type XbaI fragment was 12.5 kb. (B) Greater than 90% of Tmem16a null pups died within 9 days of birth.
Tmem16a+/+ n= 19, Tmem16a+/− n= 40, Tmem16a−/− n= 22. (C) Tmem16a null pups failed to thrive in the postnatal period. Data shown is mean weight±SEM. Tmem16a+/+ n= 7,
Tmem16a+/− n= 19, Tmem16a−/− n= 8. (D) Ventral view of whole mount tracheae from 3 day-old (P3) wild type and Tmem16a−/− pups stained with alcian blue to reveal tracheal
cartilage rings. Gaps are observed along the ventral aspect of mutant tracheae. (E, F) Transverse sections of a newbornwild type and Tmem16a−/− tracheae stainedwith alcian blue and
eosin demonstrated multiple lateral cartilage elements with intervening epithelial evaginations in mutants instead of a single ventrolateral cartilage ring (compare E and F). Scale
bar=100 μm.
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suggested that the ventral mesenchymal cells in Tmem16a mutants
were speciﬁed to undergo chondrogenesis and that upstream
paracrine signaling events required for that speciﬁcation were not
disrupted. However, at E14.5 the SOX9-positive cells were partitioned
by the epithelium into separate populations in Tmem16a mutants
(compare Figs. 3C and F). These data suggested that prechondrocytes
were present in the mutant ventral tracheal mesenchyme but ul-
timately gave rise to disconnected chondrogenic condensations.
The disruption of the mesenchymal chondrogenic condensations
was not due to anomalous cell death or cell proliferation. TdT-mediated
dUTP nick end labeling (TUNEL) did not reveal any apoptotic nuclei in
mutant tracheae at any stage examined (data not shown). In addition,
5′-bromo-2′-deoxyuridine (BrdU) incorporation did not reveal a change
in the proliferative indices of mutant tracheal mesenchyme at E13.5 or
the tracheal epithelium at E14.5 (Supplementary Fig. 1).
Abnormal morphology of the trachealis muscle in Tmem16a mutants
Since the developing trachealis muscle expressed high levels of
Tmem16a (Figs. 1D–F) and is closely associated with the tracheal
epithelium and cartilage rings, we examined its development in
Tmem16a mutants. Immunoﬂuorescence with an antibody directed
against α-smooth muscle actin revealed a population of smooth
muscle cells dorsal to the tracheae in both wild type and Tmem16amutants at E14.5 (Figs. 3G, H). In wild type mice (n= 3), spindle-
shaped cells spanned the entire dorsal aspect of the developing
trachea (Fig. 3G). In Tmem16a mutants (n= 3), the distribution of α-
smooth muscle actin-positive cells in the trachealis was severely
disrupted. Instead of ﬁlaments that spanned the dorsal trachea, we
detected this protein with a globular distribution in a cluster of cells
dorsal to the trachea in Tmem16a mutants at E14.5 and E18.5 (Fig. 3H
and Supplementary Fig. 2). This suggested that TMEM16A was
necessary for normal development of the trachealis muscle.
Increased tracheal circumference in Tmem16a null mice
Epithelial evaginations that disrupted the chondrogenic condensa-
tions in the ventral tracheal mesenchyme occurred along the entire
rostrocaudal axis of Tmem16amutant tracheae (Figs. 2D, F and 3) andwe
reasoned that this could result from an increase in the circumference of
the epithelial tube. In support of this hypothesis, the lumens of mutant
tracheae appeared dilated in comparison to those of wild type tracheae
(see Figs. 3 and 4). To quantify this defect, we photographed transverse
histological sections of tracheae from Tmem16amutants and littermates
at E13.5 and E14.5 (one section per animal) at the same relative
rostrocaudal location. For each image, the luminal circumference of the
trachea was measured by outlining the apical surface of the tracheal
epithelium using image analysis software (see Materials and methods).
At E13.5, the luminal circumference was nearly 40% greater in mutants
Fig. 3. Tracheal lumen expansion in Tmem16a mutants redirects chondrogenesis in the surrounding mesenchyme. (A–F) Immunolocalization of SOX9 in wild type and Tmem16a mutant
tracheae. At E12.5 and E13.5,Sox9-expressing cells encircled the ventrolateral aspect ofwild type (A, B) and Tmem16amutant (D, E) tracheae. This distributionpersisted inwild type tracheae at
E14.5 (C). (F) At E14.5, the epitheliumof Tmem16amutant tracheawas thinner and evaginated into the surroundingmesenchyme (F, arrowsmark evaginations disruptingmesenchymal Sox9-
positive condensations). (G)α-smoothmuscle actin immunoﬂuorescence showed the trachealis muscle dorsal to wild type tracheae at E14.5. (H) The distribution ofα-smoothmuscle actin-
positive cellswasdisrupted inTmem16amutants. (I) The tracheal lumenwas expanded inTmem16amutantswhencompared to control lumens at E13.5 (Tmem16a+/−) or E14.5 (Tmem16a+/− and
Tmem16a+/+ combined). Data shown is the average± SEM for each data point b0.06. Abbreviations: Es, esophagus; Tm, trachealis muscle. Scale bars A=100 μm; G=50 μm.
146 J.R. Rock et al. / Developmental Biology 321 (2008) 141–149(n= 2) than heterozygous controls (n= 2) (Fig. 3I). This defect was even
more severe in E14.5 embryos where the epithelial circumference of
Tmem16a mutants (n= 3) was 50% larger than wild type and hetero-
zygous littermates (n= 3) (Fig. 3I).
Ciliated cells are absent from evaginated regions of the tracheal epithelium
The disorganization of Tmem16a mutant tracheal epithelium
might have been attributable to abnormal differentiation of epithelial
cell types. Ciliated columnar cells and non-ciliated secretory Clara
cells are abundant in the mature tracheal epithelium of the mouse
(Rawlins and Hogan, 2006). Although a population of p63-expressing
cells is found in the wild type embryonic tracheal epithelium, mature
basal cells are not established until late gestation (Daniely et al., 2004).
To assess differentiation, we immunolocalized markers of these epi-
thelial cell types in mutant and wild type newborn tracheae.
Acetylated α-tubulin is localized to the cilia on the apical surfaces
of epithelial cells in the trachea (Gomperts et al., 2004). Immuno-
ﬂuorescence on newborn wild type trachea sections revealed an even
distribution of ciliated cells around the tracheal epithelium (Fig. 4A).
In Tmem16amutant trachea, we observed ciliated cells in the tracheal
epithelium with a relatively normal distribution (Fig. 4B); the oneexception was the evaginated epithelium that persisted until birth.
These regions of the mutant tracheae were conspicuously devoid of
ciliated cells (arrow in Fig. 4B). Since ciliated cellswerepresent throughout
most of the mutant trachea, we propose that this is the result of the
evagination and juxtaposition of two apical surfaces and not a defect in
speciﬁcation of the ciliated lineage. Apical localization of ezrin, a member
of the ERM (ezrin, radixin,moesin) protein family, precedes the formation
of cilia in tracheal epithelium in air–liquid interface conditions (Huang et
al., 2003). We observed normal apical distribution of ezrin in ciliated cells
of Tmem16amutants (data not shown).
Secretory Clara cells of the murine tracheal epithelium can be
identiﬁed by the presence of the secretoglobin Scgb1a1 (Perl et al.,
2005). We detected Clara cells throughout the tracheal epithelium
of newborn wild type and Tmem16a mutant pups (Figs. 4A, B). In
particular, we detected Scgb1a1-expressing cells in regions of tracheae
that had undergone abnormal epithelial evagination.
In the mature pseudostratiﬁed epithelium of the mouse trachea, a
discontinuous population of basal cells can be identiﬁed by expres-
sion of the transcription factor p63 (Daniely et al., 2004). As a
multipotent progenitor cell type of the proximal airways, basal cells
are capable of restoring tracheal epithelial cell diversity following
injury (Hong et al., 2004). In newborn mice, we observed a normal
Fig. 4. Tmem16a mutant epithelium contains Clara, basal, and ciliated cells, but is improperly organized during embryogenesis. (A) Acetylated α-tubulin and Scgb1a1 reveal
distribution of ciliated (red) and Clara cells (green) respectively in wild type newborn tracheal epithelium. (B) Ciliated (red) and Clara cells (green) were present in Tmem16amutant
tracheal epithelium. However, only Clara cells and no ciliated cells were found in regions of epithelial evagination (arrow). (C, D) Basal cells are identiﬁed by p63 im-
munohistochemistry in the epithelium of newbornwild type (C) and Tmem16amutant (D) tracheae. (E) Cdh1 immunoﬂuorescence and DAPI revealed epithelial cell membranes and
nuclei, respectively, in wild type tracheal epithelium at E14.5. The epithelium comprised 2–3 layers of cells. (F) Cdh1 immunoﬂuorescence reveals a thinner epithelium in Tmem16a
mutant tracheae at E14.5 with aberrant stratiﬁcation (1–2 cell layers thick) and an expanded tracheal lumen. Panels G and H are increased magniﬁcation of panels E and F. Dashed
lines delineate the epithelium. Scale bars (A, C, D)=50 μm; (E, F)=48 μm; (G, H)=16 μm.
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epithelium (Figs. 4C, D).
Embryonic tracheal epithelium stratiﬁcation is lost in Tmem16a mutants
Since we did not observe a change in proliferation, apoptosis or
differentiation in Tmem16a mutant tracheal epithelium, we reasoned
that the luminal expansion could result from an abnormal arrange-
ment of epithelial cells. The mid-gestational tracheal epithelium of
the mouse is reported to comprise 2 to 3 cell layers (Daniely et al.,2004). To assess tracheal epithelium organization in Tmem16a
mutants, we performed immunoﬂuorescence on transverse sections
of Tmem16a mutant and wild type tracheae with a Cdh1 antibody to
identify basolateral epithelial cell plasma membranes. Sections were
counterstained with 4′,6-Diamidino-2′-phenylindole (DAPI) to reveal
nuclei. In contrast to the stratiﬁed epithelium of the E14.5 wild type
tracheae, a majority of the nuclei in the mutant tracheae were
located adjacent to the basement membrane (Figs. 4E–H). As a result
of this lateral arrangement of cells, the epithelium was observably
thinner.
148 J.R. Rock et al. / Developmental Biology 321 (2008) 141–149Discussion
A novel etiology for tracheomalacia in a murine model
The formation of tracheal cartilage rings normally occurs in the
ventrolateral mesenchyme around the tracheal epithelium during
mid-embryogenesis. Since Tmem16a was never expressed in the
chondrogenic mesenchyme of the trachea, we propose that the
cartilage defect observed in Tmem16a mutants was a consequence of
the improper organization of Tmem16a mutant tracheal epithelium
and/or trachealis muscle where Tmem16awas expressed. We detected
a normal population of SOX9-positive prechondrocytes in Tmem16a
mutants prior to the appearance of an expanded tracheal lumen,
anormal trachealis muscle, and improperly stratiﬁed embryonic
epithelium. We propose that these primary defects caused evagina-
tions of the tracheal epithelium into the surrounding mesenchyme
that disrupted the chondrogenic condensations of the tracheal
cartilage rings. The ventral-most SOX9-positive chondrocytes were
either physically displaced or respeciﬁed as another cell type as a
result of the epithelial and smooth muscle defects in Tmem16a
mutants. Instead of the C-shaped rings required to prevent the trachea
from collapsing during normal respiration, multiple cartilaginous
rudiments formed along the entire length of the trachea.
This abnormal arrangement of tracheal cartilage contributed to
the aerophagia, cyanosis, and failure to thrive of postnatal Tmem16a
mutants. In humans, tracheomalacia is exacerbated by esophageal
expansion during feeding and can lead to a failure to thrive similar
to what we observed in Tmem16a mutant mice (Ahel et al., 2003).
We are unaware of human patients with the type of primary
tracheomalacia observed in Tmem16a mutant mice; however, it is
conceivable that trauma, surgery, or unidentiﬁed human mutations
could result in similar ventral gaps in the tracheal cartilage rings of
humans.
Alternative models for the etiology of the tracheomalacia observed
in Tmem16amutant mice exist. It is possible that deletion of Tmem16a
from the tracheal epithelium disrupts paracrine signaling from the
epithelium to the mesenchyme. Since Sox9 is expressed in Tmem16a
mutants in a complete ventrolateral ring of cells surrounding the
trachea that do not exhibit a proliferative or apoptotic defect prior to
chondrogenesis, we do not believe that this is the case. Instead, our
data suggests that the upstream signaling events required for
chondrogenesis occurred in the ventral mesenchyme of Tmem16a
mutant tracheae.
Defective development of the trachealis muscle in Tmem16a mutants
We identiﬁeda defect in the developmentof the trachealismuscle in
Tmem16amutant mice. In wild type animals this smooth muscle spans
the dorsal gaps in the rings of tracheal cartilage and controls the size of
the lumen during respiration (Hakansson et al., 1976). One possibility is
that this muscle functions during embryogenesis and is required for
normal development of the trachea. It is currently not knownwhether
the defect we observed in the trachealis muscle in Tmem16a mutants
contributed to the expansion of the tracheal lumen, abnormal epithelial
morphogenesis, and/or abnormal cartilage ring development. We are
not aware of other mutants with similar patterning defects in the
trachealis muscle as observed in Tmem16a null mice.
Interestingly, the paralog Tmem16a is upregulated during differ-
entiation of muscle in vitro and is associated in vivo with cardiac and
skeletal muscle (Mizuta et al., 2007; Tsutsumi et al., 2005). Tmem16a,
Tmem16e, and other paralogs are expressed in other, non-muscular
tissues suggesting that their functions are not speciﬁc to muscle
development (Bera et al., 2004; Mizuta et al., 2007; Rock et al., 2007).
However, the functions of the protein products of these genes might
be essential for normal organization or function of muscle and other
tissues.Abnormal morphogenesis of the tracheal epithelium in Tmem16a
mutants
We report that mice lacking the transmembrane protein TMEM16A
demonstrate defects in organization of the tracheal epithelium during
embryogenesis. The cells of the epithelium fail to stratify and most
nuclei are located in close proximity to the basement membrane. The
defective stratiﬁcation is not the result of a global loss in apicobasal
polarity or improper localization of proteins to the apical surface; in
ciliated cells of Tmem16a mutant tracheae, both the cilia and the
cytoskeletal linker protein ezrin were properly localized to the apical
surface. Furthermore, we demonstrated normal differentiation of
Clara cells, ciliated cells, and basal cells in mutant tracheae.
Previous experiments have shown that oriented and asymmetric
cell divisions are necessary for stratiﬁcation of the skin (Lechler and
Fuchs, 2005). One possibility is that similar asymmetric cell divisions
are also necessary for tracheal epithelial stratiﬁcation and require
TMEM16A. In support of this hypothesis, Ist2p, the only TMEM16
ortholog identiﬁed in the yeast Saccharomyces cerevisiae, has been
shown to sort asymmetrically during budding (Takizawa et al., 2000).
This protein, however, is distantly related to TMEM16A and does not
necessarily share the same function or distribution.
One vertebrate paralog of TMEM16A, TMEM16E, has been localized
primarily to intracellular membranes in cultures of myotubes (Mizuta
et al., 2007). For the paralog TMEM16G (also known as NGEP), one
splice isoform has been reported intracellularly while a second
isoform has been identiﬁed on the plasma membrane (Bera et al.,
2004). We showed that TMEM16A is localized to the plasma
membranes of KLN 205 murine lung carcinoma cells where it is
possible that this protein mediates cell:cell contacts, intercellular
communication, or cellular morphology. The paralog TMEM16G has
been shown to promote adhesion between LNCaP cells in culture
where it is localized to the plasma membrane in regions of cell:cell
contact (Das et al., 2007). A loss of adhesion between Tmem16a
mutant cells could explain the lateral arrangement of cells and lack of
stratiﬁcation of Tmem16a mutant trachea epithelium.
A murine model of tracheomalacia
In humans, the diagnosis of tracheomalacia is complicated because
its symptoms overlap with those of other pulmonary disorders and
there is no single etiology for this condition. In many cases of
tracheomalacia, the condition is self-limiting and conservative
treatment is favored (Carden et al., 2005; Greenholz et al., 1986). In
more severe cases, treatment including ventilation and surgery are
required. In addition to identifying a novel etiology for tracheomala-
cia, the Tmem16a mutant mice provide a murine model of severe
primary tracheomalacia that could be used to aid in the diagnosis and
treatment of this condition.
Currently, very little is known about the embryology and mo-
lecular biology of normal tracheal development. We propose that
there is a requirement for stratiﬁcation of themid-gestational tracheal
epithelium in normal development and identify Tmem16a as a novel
mediator of development of the tracheal epithelium and trachealis
muscle. Furthermore, we show that TMEM16A is required for normal
development of the tracheal cartilage rings and that deletion of this
protein results in severe primary tracheomalacia in mice.
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